Pietro A. Canetta, MD, recounts how, as a young nephrologist at Columbia University, he was encouraged by a mentor to give a talk on IgA nephropathy, a topic that at the time had limited research and few studies. Over the past 15 years, however, the field has drastically changed, with new FDA-approved drugs, numerous clinical trials, and groundbreaking publications in top medical journals.
This rapid progress has made Dr Canetta’s work exciting and keeps him engaged, as the science evolves quickly and requires constant updates to his presentations. He finds the ongoing advances inspiring, not only for his work but also for the hope it brings to patients, who often reach out to discuss the latest developments.
